
DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.
Blue Star Capital Plc (LON:BLU) recently invested in digital payment company SatoshiPay. The successful funding was lead by early supporter Jim Mellon. With blockchain technology having the potential to revolutionise..
Surface Transforms Plc (LON:SCE) Chairman David Bundred catches up with DirectorsTalk to discuss announcements made since we last spoke. David talks about the importance of the deal with Aston Martin,..
Lighthouse Group Plc (LON:LGT) CEO Malcolm Streatfield talks to DirectorsTalk about the strong set of results for 2016 issued. Malcolm talks us through the highlights, explains the sunset clause arrangements..
City of London Investment Group Plc (LON:CLIG) is the topic of discussion when Robin Savage, Research Director at Zeus Capital caught up with DirectorsTalk. Robin compares the interim results for..
Goldplat Plc (LON:GDP) are the topic of discussion when Oliver O’Donnell, mining analyst at VSA Capital caught up with DirectorsTalk to discuss company interims. Oliver discusses 2016 issues, how currency..
Versarien Plc (LON:VRS) the advanced materials group, CEO Neill Ricketts talks to DirectorsTalk about its agreement with Lansdowne Chemicals. Neill explains the background to the deal, its significance, how they..
“Expand our horizons dramatically”, “Boots on the ground”, “Very confident in the future” are just some of the phrases Keith Allaun, Executive Chairman for PowerHouse Energy Group Plc (LON:PHE) uses..
Allergy Therapeutics Plc (LON:AGY) is the topic of conversation with Dr Gary Waanders Director of Healthcare Research at Zeus Capital. Since Allergy Therapeutics announced today that it has obtained approval..
Falanx Group Ltd (LON:FLX) Cyber Defence Executive Director Jay Abbott talks to DirectorsTalk about the set up of its new Falanx Cyber Technologies unit. Jay provides an update on how..
KEFI Minerals Plc (LON:KEFI) Executive Chairman Harry Anagnostaras-Adams talks to DirectorsTalk about a conditional fundraising to raise £5.62m. Harry talks us through the announcement, explains why a new major institutional..
Ascent Resources plc (LON:AST) CEO Colin Hitchinson talks to DirectorsTalk about its fund raise this weekend of £3m. Colin talks us through the fund raise and proceeds will be used..
Georgian Mining Corp (LON:GEO) Managing Director Greg Kuenzel talks to DirectorsTalk about the near surface intercepts from the first three drill holes at the Bolnisi Project in Georgia. Greg talks..
Oncimmune Holdings Plc (LON:ONC) is the topic of conversation when Dr Gary Waanders the Director of Healthcare Research at Zeus Capital caught up with DirectorsTalk. Gary talks us through the..
Powerhouse Energy Group Plc (LON:PHE) Executive Chairman Keith Allaun talks to DirectorsTalk about the latest news from the company. Keith expands on the appointment of Waste2tricity as a Project Development..
Morses Club Plc (LON:MCL) is the topic of discussion when Mark Thomas Analyst at Hardman and Co talks to DirectorsTalk. Mark explains whats attractive about the market its in, why..
Versarien Plc (LON:VRS) CEO Neill Ricketts talks to DirectorsTalk about the launch of its new brand ‘Nanene’. Neill explains what it is, what it will be used for, other areas..
Proteome Sciences Plc (LON:PRM) today provided a trading update for the 12 months ending 31 December 2016. CEO Jeremy Haigh talks to DirectorsTalk about its strong trading update issued today...
Optibiotix Health Plc (LON:OPTI) CEO Stephen O’Hara talks to DirectorsTalk about a string of news since Christmas, Stephen gives us an overview of the company’s progress and plans for 2017...
AdEPT Telecom plc (LON:ADT) CFO John Swaite talks to DirectorsTalk about its new finance package and acquisition. John provides a summary of the new finance package, explains the strategic rationale..










































